Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06789718 · ClinicalTrials.gov registry record
Impact of GABA Probiotic Lactiplantibacillus Plantarum Lp815 on Sleep Outcomes in Participants with Self-Reported Sleep Disturbance
A clinical trial of Insomnia (moderate), sponsored by Verb Biotics.
- Active
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT06789718 is a study of Insomnia (moderate) that is active but no longer recruiting, run by Verb Biotics. The registered enrollment target is 150 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06789718, a study of Insomnia (moderate), is active but no longer recruiting, sponsored by Verb Biotics.
- ACTIVE NOT RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The rationale for this study is to observe differences in sleep outcomes between a consumer-grade probiotic capsule called GABA Probiotic and a placebo control group. Additionally, the study aims to evaluate the impact of the probiotic product on anxiety, gastrointestinal symptoms, sleep quality, daytime alertness, mood, stress, severity of night sweats (if present), and quality of life. In a subset of participants, the study also aims to evaluate how the probiotic affects neurotransmitter levels in the body using an at-home urinary test. A consumer-driven, decentralized observational clinical research study is therefore well-suited for evaluating the impact of this probiotic product in this population.
Conditions Studied
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT GABA Probiotic Lactiplantibacillus plantarum Lp815 (5 Billion cfu/dose)
- DIAGNOSTIC_TEST Optional Sub-Study: Neurotransmitter Urine Test
Study Locations (1)
California
- People Science, Inc. - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2024-11-04 |
| Est. Completion | 2025-03-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06789718
The ClinicalTrials.gov registry entry for NCT06789718 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Verb Biotics, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Insomnia (moderate) appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT06789718 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06789718 about?
NCT06789718 is a clinical study titled "Impact of GABA Probiotic Lactiplantibacillus Plantarum Lp815 on Sleep Outcomes in Participants with Self-Reported Sleep Disturbance". The rationale for this study is to observe differences in sleep outcomes between a consumer-grade probiotic capsule called GABA Probiotic and a placebo control group. Additionally, the study aims to evaluate the impact of the probiotic product on anxiety, gastrointestinal symptoms, sleep quality, da...
What is the current status of trial NCT06789718?
This trial is currently active not recruiting. The enrollment target is 150 participants. The study started on 2024-11-04. Estimated completion is 2025-03-01.
What conditions does trial NCT06789718 study?
This clinical trial studies the following conditions: Insomnia (moderate).
What interventions are being tested in trial NCT06789718?
The interventions under investigation include: Placebo (OTHER), GABA Probiotic Lactiplantibacillus plantarum Lp815 (5 Billion cfu/dose) (DIETARY_SUPPLEMENT), Optional Sub-Study: Neurotransmitter Urine Test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06789718?
This trial is sponsored by Verb Biotics, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06789718 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.